Efficacy of intravenous immune globulin for treatment of experimental pseudomonas aeruginosa pneumonia
- 31 March 1986
- journal article
- Published by Elsevier in Journal of Critical Care
- Vol. 1 (1) , 4-10
- https://doi.org/10.1016/s0883-9441(86)80111-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The Outlook for Prevention and Treatment of Infections Due to Pseudomonas aeruginosaClinical Infectious Diseases, 1984
- Bacteremic Nosocomial PneumoniaAmerican Review of Respiratory Disease, 1984
- Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosaThe American Journal of Medicine, 1984
- Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.Journal of Clinical Investigation, 1982
- Epidemiology of Nosocomial Infections Due to Gram-Negative Bacilli: Aspects Relevant to Development and Use of VaccinesThe Journal of Infectious Diseases, 1977
- Use of a Pseudomonas aeruginosa vaccine in patients with acute leukemia and cystic fibrosisThe American Journal of Medicine, 1975
- Bacteremic Pseudomonas pneumoniaPublished by American Medical Association (AMA) ,1974
- Pneumonia in an intensive care unit. A 30-month experienceArchives of internal medicine (1960), 1974
- Pseudomonas pneumoniaThe American Journal of Medicine, 1973
- The Separation of the Antibodies, Isoagglutinins, Prothrombin, Plasminogen and β1-Lipoprotein into Subfractions of Human PlasmaJournal of the American Chemical Society, 1949